Striatal and Extra-striatal Dopamine Release in Response to Food in Healthy Humans (DA-Fallypride)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02310360|
Recruitment Status : Unknown
Verified October 2016 by Universitaire Ziekenhuizen Leuven.
Recruitment status was: Active, not recruiting
First Posted : December 8, 2014
Last Update Posted : October 27, 2016
|Condition or disease||Intervention/treatment|
|Appetite Regulation||Radiation: Fallypride|
|Study Type :||Observational|
|Actual Enrollment :||12 participants|
|Official Title:||Measuring Food-induced Striatal and Extra-striatal Dopamine Release Using (18F)Fallypride Positron Emission Tomography|
|Study Start Date :||November 2014|
|Actual Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||March 2017|
- DA release in both striatal and extra-striatal brain regions [ Time Frame: 1 year ]A [18F]Fallypride PET protocol and the linearized simplified reference region model (LSSRM) kinetic model will be used to detect DA release.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02310360
|University Hospitals Leuven, campus Gasthuisberg|
|Leuven, Belgium, 3000|
|Principal Investigator:||Lukas Van Oudenhove, MD, PhD||University Hospitals Leuven, campus Gasthuisberg|